VictoriaGray United States

VictoriaGray
Victoria Gray was the 1st Sickle Cell Anemia patient in the world to be treated with CRISPR gene editing in 2019. After a lifetime of pain, treatments, and hospitalizations for Sickle Cell Disease, she is now symptom-free, working as a patient advocate and international speaker to spread the word about CRISPR and rare diseases to clinicians, scientists, patients, and students. Mrs. Gray is a wife and mother of four children and lives in Forest, Mississippi.
Institution

Day 1 - Sunday April 14, 2024

Time Session
11:00
12:00
Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)
PL2
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology
Hall A